CCSD code C0840 – Orbital injection billing guide

Key takeaways

CCSD Code C0840 bills the orbital injection itself in UK private practice. The drug and any same-day consultation go on separate lines.

Thyroid eye disease and orbital pseudotumour (idiopathic orbital inflammation) are typical indications, and each claim needs a linked ICD-10 diagnosis code.

Code the drug on its own line with the insurer’s drug or consumable code, or the claim risks rejection or under-payment.

Retrobulbar, sub-Tenon and peri-orbital approaches are typically billed under C0840, but confirm with the insurer’s code search first.

Pabau’s claims management software pulls the patient, treatment and insurer details from the record into a pre-filled Healthcode claim.

CCSD Code C0840: definition and scope

CCSD Code C0840 is the procedure code for an orbital injection in the CCSD schedule, the standard billing language for UK private medical practice. The schedule is maintained by the Clinical Coding and Schedule Development (CCSD) Group (Aviva, AXA Health, Bupa, Vitality).

Consultant ophthalmologists and oculoplastic surgeons use C0840 to bill for the injection itself: introducing a therapeutic agent into or around the orbital space. The drug and any preceding consultation are billed separately. Insurer fee schedules band C0840 as a minor procedure.

The CCSD code set is distinct from CPT, which is used in the United States, and from the OPCS-4 codes used for NHS procedures. C0840 applies to UK private practice claims, which go to insurers, typically through Healthcode. The CCSD Group publishes the codes but does not receive claims.

C0840 sits in chapter 4 of the schedule, Eye and orbital contents. Open orbital surgery carries its own codes. Drainage of the orbit is billed as C0620, and exploration of the orbit as C0650.

What does an orbital injection involve?

An orbital injection is the delivery of a therapeutic agent into the orbital space: the bony cavity surrounding the eye and its supporting structures. The procedure targets tissue within or immediately next to the orbit rather than the eye itself. That separates it from intravitreal injections into the vitreous cavity and subconjunctival injections beneath the conjunctiva.

Three anatomical approaches are used in clinical practice. Each is typically billed under C0840, but confirm with the insurer’s code search:

• Retrobulbar injection: the agent is delivered behind the globe, into the retrobulbar space. Commonly used for anaesthetic block or orbital depot corticosteroid.
• Sub-Tenon injection: the agent is deposited beneath Tenon’s capsule, the fibrous envelope surrounding the globe. Widely used for posterior segment drug delivery and orbital inflammatory conditions.
• Peri-orbital / transcutaneous injection: the agent is injected directly into the orbital fat or periorbital tissues through the eyelid skin, typically for inflammatory orbital disease.

A retrobulbar anaesthetic block given as part of another procedure is normally not billed separately under C0840.

Corticosteroids are the most commonly injected agents: triamcinolone acetonide, methylprednisolone, and dexamethasone are all used depending on indication, payer policy, and consultant preference. The route, drug, and dose must be documented in the procedure note to support both the C0840 claim and any separately coded drug/consumable claim.

Clinical indications supported by C0840

CCSD Code C0840 needs a linked ICD-10 diagnosis code for the claim to pass a private medical insurer’s (PMI’s) medical necessity review. Typical diagnoses fall into four groups.

PMI policies on medical necessity vary by insurer and by the individual patient’s plan. A diagnosis code alone does not guarantee approval. Clinical justification in the procedure note, cross-referenced with a preauthorisation reference number, is what the claims team uses to confirm coverage.

What CCSD Code C0840 includes and what it excludes

Coding errors on C0840 claims fall into two patterns: under-billing (not coding the drug separately) and over-billing (including items already bundled into the procedure code). The table below sets out the boundary.

Verify the drug or consumable code against the insurer’s current schedule before submitting. Codes can change between schedule editions, so last year’s code for triamcinolone acetonide may no longer apply.

How C0840 differs from neighbouring eye injection codes

A common miscoding error on C0840 claims is confusing the orbital injection with nearby eye procedures that carry their own CCSD codes. They differ by anatomical target, clinical purpose and code. An injection into the front chamber of the eye, for example, is billed as C6930.

Sub-Tenon and retrobulbar injections are typically billed under C0840, because both deliver the agent into or behind the orbital space. The schedule entry reads only “Orbital injection”, so confirm with the insurer’s code search. The full CCSD code lookup lists every other entry by chapter.

The map below shows which code each injection target takes, from the orbit inwards.

Documentation required to support a C0840 claim

Incomplete documentation is a common cause of C0840 claim failure. PMIs expect a procedure record that lets their clinical reviewers confirm medical necessity, the procedure performed and the materials used. The General Medical Council’s guidance on clinical records sets the professional standard, and PMIs use a similar framework for claim adjudication.

A compliant procedure note for a C0840 claim should include all of the following:

• Date and location of procedure (hospital or practice name, consultant name and GMC number)
• Diagnosis with ICD-10 code (e.g. E05.0 with H06.2 for thyroid eye disease) confirming the clinical indication
• Approach used (retrobulbar, sub-Tenon, transcutaneous peri-orbital) and anatomical laterality (right, left, bilateral)
• Drug name, concentration, and dose administered (e.g. triamcinolone acetonide 40 mg/mL, 1 mL)
• Patient response or tolerance note (brief; confirms the procedure was completed and documents any immediate adverse effect)
• Preauthorisation reference number from the relevant PMI, where authorisation was obtained before the procedure
• Consent record confirming the patient received a procedure-specific explanation of risks and benefits

Digital procedure and consent forms capture this data at the point of care, so nobody has to rebuild the documentation afterwards. Make every field listed above mandatory in the practice’s ophthalmology procedure template.

Preauthorisation requirements for C0840

Most UK PMIs require preauthorisation (also called prior authorisation or pre-auth) before an orbital injection proceeds under C0840. Submitting a claim without a valid authorisation reference is a quick route to rejection.

Payer preauthorisation rules for C0840 can change between policy years. Check each payer’s provider portal before every procedure, not just at the start of the year. The Bupa CCSD code reference on Pabau covers Bupa-specific CCSD billing requirements in more detail.

How to submit a C0840 claim via Healthcode

Healthcode is the standard electronic data interchange (EDI) clearinghouse for UK private medical billing. Most major PMIs, including Bupa and AXA Health, require claims to be submitted through Healthcode rather than by paper invoice. Practices using a practice management system with Healthcode integration can submit C0840 claims directly from the patient record.

A compliant C0840 claim submission via Healthcode follows these steps:

1. Create the patient invoice in your practice management system. Attach the C0840 procedure code, the relevant CCSD drug/consumable code, and the outpatient consultation code if billed on the same date.
2. Link the ICD-10 diagnosis code to the C0840 line item. The payer’s adjudication system validates that the diagnosis supports the procedure. Missing or mismatched diagnosis codes trigger automatic review.
3. Enter the preauthorisation reference number in the designated field on the claim. This is mandatory when prior authorisation was obtained. A blank field on a procedure that required pre-auth will result in rejection.
4. Attach the procedure note as a supporting document where the payer’s EDI format supports it. Some insurers ask for it on orbital procedures.
5. Submit the claim through Healthcode and retain the submission confirmation reference. Payment timelines vary by payer agreement.
6. Monitor the remittance and match payments against the submitted invoice. Partial payments often indicate a line-item query, not a full rejection. Query these at line-item level rather than resubmitting the whole claim.

Common reasons C0840 claims are denied

C0840 claim denials tend to follow five patterns. Most can be prevented while the claim is prepared, long before an appeal.

When a claim is denied for medical necessity, start with the diagnosis. Check that the ICD-10 code on the claim exactly matches the condition described in the procedure note. An H05.1 (orbital pseudotumour) claim that uses a nonspecific H05.9 code will fail medical necessity review at most payers. A pre-submission check that compares the diagnosis code with the procedure note catches this before the claim goes out.

How Pabau keeps C0840 claims moving through Healthcode

Many ophthalmology practices still build C0840 claims by hand. Someone copies the procedure, drug and authorisation details from the note into the insurer’s form, and each copy is a chance for an error.

Pabau, the practice management platform we build, pulls the patient, treatment and insurer details straight from the patient record into a pre-filled claim. Our claims management software then sends it to Healthcode, so the C0840 line, drug line and consultation line leave together.

Before each claim goes, Pabau checks that insurer details such as membership numbers and authorisation codes are in place. That catches a missing pre-auth reference, the first denial pattern above, before the insurer sees the claim.

Send cleaner C0840 claims to Healthcode

Pabau pulls the patient, treatment and insurer details from the record into a pre-filled Healthcode claim. It checks membership and authorisation numbers before the claim goes.

Book a demo

Conclusion

C0840 is a minor code, but the claim around it has several moving parts. Bill the injection, the drug and any consultation as separate lines, and keep the authorisation reference on the claim.

Where the answer turns on the insurer, ask the insurer. The approach, a second side and botulinum toxin to the eye muscles all depend on the insurer’s code search or bilateral rule. Check those before the procedure date rather than after a rejection.

To see how Pabau carries a C0840 claim from the procedure note to Healthcode, book a demo.

Continue your research

Need a full Bupa CCSD code reference? Bupa CCSD codes covers the full schedule of CCSD codes recognised by Bupa for UK private practice billing.

Billing an orbital drainage instead? CCSD code C0620 covers drainage of the orbit, with fees and insurer billing steps.

Billing open orbital surgery? CCSD code C0650 explains exploration of the orbit as a sole procedure.

Injecting the front of the eye? CCSD code C6930 walks through anterior chamber injection billing.

Choosing a system for Healthcode claims? Best medical billing software in the UK compares billing systems for UK private practices.

Frequently asked questions